Selected research
Market Analysis & Forecast
Global Eszopiclone Drug Market Analysis and Forecast 2026-2032
Market perspective
The global Eszopiclone Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Eszopiclone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Eszopiclone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Eszopiclone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Eszopiclone Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Eszopiclone Drug include Teva, Sun Pharmaceutical, Mylan, West Ward Pharmaceuticals, Sunovion, McKesson Medical-Surgical, Lupin Pharmaceuticals, Glenmark Pharmaceuticals and Dr. Reddy's Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Eszopiclone Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Eszopiclone Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Eszopiclone Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Eszopiclone Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Eszopiclone Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Eszopiclone Drug sales, projected growth trends, production technology, application and end-user industry.
Eszopiclone Drug Segment by Company
Teva
Sun Pharmaceutical
Mylan
West Ward Pharmaceuticals
Sunovion
McKesson Medical-Surgical
Lupin Pharmaceuticals
Glenmark Pharmaceuticals
Dr. Reddy's Laboratories
Aurobindo Pharma
Eszopiclone Drug Segment by Type
1 mg Tablets
2 mg Tablets
3 mg Tablets
Eszopiclone Drug Segment by Application
Hospital
Drug store
Eszopiclone Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Eszopiclone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Eszopiclone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Eszopiclone Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Eszopiclone Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Eszopiclone Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eszopiclone Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1 mg Tablets
- 2 mg Tablets
- 3 mg Tablets
Applications
- Hospital
- Drug store
Companies covered
- Teva
- Sun Pharmaceutical
- Mylan
- West Ward Pharmaceuticals
- Sunovion
- McKesson Medical-Surgical
- Lupin Pharmaceuticals
- Glenmark Pharmaceuticals
- Dr. Reddy's Laboratories
- Aurobindo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Eszopiclone Drug Market by Type
- 1.2.1 Global Eszopiclone Drug Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 1 mg Tablets
- 1.2.3 2 mg Tablets
- 1.2.4 3 mg Tablets
- 1.3 Eszopiclone Drug Market by Application
- 1.3.1 Global Eszopiclone Drug Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Eszopiclone Drug Market Dynamics
- 2.1 Eszopiclone Drug Industry Trends
- 2.2 Eszopiclone Drug Industry Drivers
- 2.3 Eszopiclone Drug Industry Opportunities and Challenges
- 2.4 Eszopiclone Drug Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Eszopiclone Drug Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Eszopiclone Drug Revenue by Region
- 3.2.1 Global Eszopiclone Drug Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Eszopiclone Drug Revenue by Region (2021-2026)
- 3.2.3 Global Eszopiclone Drug Revenue by Region (2027-2032)
- 3.2.4 Global Eszopiclone Drug Revenue Market Share by Region (2021-2032)
- 3.3 Global Eszopiclone Drug Sales Estimates and Forecasts 2021-2032
- 3.4 Global Eszopiclone Drug Sales by Region
- 3.4.1 Global Eszopiclone Drug Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Eszopiclone Drug Sales by Region (2021-2026)
- 3.4.3 Global Eszopiclone Drug Sales by Region (2027-2032)
- 3.4.4 Global Eszopiclone Drug Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Eszopiclone Drug Revenue by Manufacturers
- 4.1.1 Global Eszopiclone Drug Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Eszopiclone Drug Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Eszopiclone Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Eszopiclone Drug Sales by Manufacturers
- 4.2.1 Global Eszopiclone Drug Sales by Manufacturers (2021-2026)
- 4.2.2 Global Eszopiclone Drug Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Eszopiclone Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Eszopiclone Drug Sales Price by Manufacturers (2021-2026)
- 4.4 Global Eszopiclone Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Eszopiclone Drug Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Eszopiclone Drug Manufacturers, Product Type & Application
- 4.7 Global Eszopiclone Drug Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Eszopiclone Drug Market CR5 and HHI
- 4.8.2 2025 Eszopiclone Drug Tier 1, Tier 2, and Tier 3
5 Eszopiclone Drug Market by Type
- 5.1 Global Eszopiclone Drug Revenue by Type
- 5.1.1 Global Eszopiclone Drug Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Eszopiclone Drug Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Eszopiclone Drug Revenue Market Share by Type (2021-2032)
- 5.2 Global Eszopiclone Drug Sales by Type
- 5.2.1 Global Eszopiclone Drug Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Eszopiclone Drug Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Eszopiclone Drug Sales Market Share by Type (2021-2032)
- 5.3 Global Eszopiclone Drug Price by Type
6 Eszopiclone Drug Market by Application
- 6.1 Global Eszopiclone Drug Revenue by Application
- 6.1.1 Global Eszopiclone Drug Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Eszopiclone Drug Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Eszopiclone Drug Revenue Market Share by Application (2021-2032)
- 6.2 Global Eszopiclone Drug Sales by Application
- 6.2.1 Global Eszopiclone Drug Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Eszopiclone Drug Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Eszopiclone Drug Sales Market Share by Application (2021-2032)
- 6.3 Global Eszopiclone Drug Price by Application
7 Company Profiles
- 7.1 Teva
- 7.1.1 Teva Company Information
- 7.1.2 Teva Business Overview
- 7.1.3 Teva Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Eszopiclone Drug Product Portfolio
- 7.1.5 Teva Recent Developments
- 7.2 Sun Pharmaceutical
- 7.2.1 Sun Pharmaceutical Company Information
- 7.2.2 Sun Pharmaceutical Business Overview
- 7.2.3 Sun Pharmaceutical Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Sun Pharmaceutical Eszopiclone Drug Product Portfolio
- 7.2.5 Sun Pharmaceutical Recent Developments
- 7.3 Mylan
- 7.3.1 Mylan Company Information
- 7.3.2 Mylan Business Overview
- 7.3.3 Mylan Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Mylan Eszopiclone Drug Product Portfolio
- 7.3.5 Mylan Recent Developments
- 7.4 West Ward Pharmaceuticals
- 7.4.1 West Ward Pharmaceuticals Company Information
- 7.4.2 West Ward Pharmaceuticals Business Overview
- 7.4.3 West Ward Pharmaceuticals Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 West Ward Pharmaceuticals Eszopiclone Drug Product Portfolio
- 7.4.5 West Ward Pharmaceuticals Recent Developments
- 7.5 Sunovion
- 7.5.1 Sunovion Company Information
- 7.5.2 Sunovion Business Overview
- 7.5.3 Sunovion Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Sunovion Eszopiclone Drug Product Portfolio
- 7.5.5 Sunovion Recent Developments
- 7.6 McKesson Medical-Surgical
- 7.6.1 McKesson Medical-Surgical Company Information
- 7.6.2 McKesson Medical-Surgical Business Overview
- 7.6.3 McKesson Medical-Surgical Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 McKesson Medical-Surgical Eszopiclone Drug Product Portfolio
- 7.6.5 McKesson Medical-Surgical Recent Developments
- 7.7 Lupin Pharmaceuticals
- 7.7.1 Lupin Pharmaceuticals Company Information
- 7.7.2 Lupin Pharmaceuticals Business Overview
- 7.7.3 Lupin Pharmaceuticals Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Lupin Pharmaceuticals Eszopiclone Drug Product Portfolio
- 7.7.5 Lupin Pharmaceuticals Recent Developments
- 7.8 Glenmark Pharmaceuticals
- 7.8.1 Glenmark Pharmaceuticals Company Information
- 7.8.2 Glenmark Pharmaceuticals Business Overview
- 7.8.3 Glenmark Pharmaceuticals Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Glenmark Pharmaceuticals Eszopiclone Drug Product Portfolio
- 7.8.5 Glenmark Pharmaceuticals Recent Developments
- 7.9 Dr. Reddy's Laboratories
- 7.9.1 Dr. Reddy's Laboratories Company Information
- 7.9.2 Dr. Reddy's Laboratories Business Overview
- 7.9.3 Dr. Reddy's Laboratories Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Dr. Reddy's Laboratories Eszopiclone Drug Product Portfolio
- 7.9.5 Dr. Reddy's Laboratories Recent Developments
- 7.10 Aurobindo Pharma
- 7.10.1 Aurobindo Pharma Company Information
- 7.10.2 Aurobindo Pharma Business Overview
- 7.10.3 Aurobindo Pharma Eszopiclone Drug Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Aurobindo Pharma Eszopiclone Drug Product Portfolio
- 7.10.5 Aurobindo Pharma Recent Developments
8 North America
- 8.1 North America Eszopiclone Drug Market Size by Type
- 8.1.1 North America Eszopiclone Drug Revenue by Type (2021-2032)
- 8.1.2 North America Eszopiclone Drug Sales by Type (2021-2032)
- 8.1.3 North America Eszopiclone Drug Price by Type (2021-2032)
- 8.2 North America Eszopiclone Drug Market Size by Application
- 8.2.1 North America Eszopiclone Drug Revenue by Application (2021-2032)
- 8.2.2 North America Eszopiclone Drug Sales by Application (2021-2032)
- 8.2.3 North America Eszopiclone Drug Price by Application (2021-2032)
- 8.3 North America Eszopiclone Drug Market Size by Country
- 8.3.1 North America Eszopiclone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Eszopiclone Drug Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Eszopiclone Drug Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Eszopiclone Drug Market Size by Type
- 9.1.1 Europe Eszopiclone Drug Revenue by Type (2021-2032)
- 9.1.2 Europe Eszopiclone Drug Sales by Type (2021-2032)
- 9.1.3 Europe Eszopiclone Drug Price by Type (2021-2032)
- 9.2 Europe Eszopiclone Drug Market Size by Application
- 9.2.1 Europe Eszopiclone Drug Revenue by Application (2021-2032)
- 9.2.2 Europe Eszopiclone Drug Sales by Application (2021-2032)
- 9.2.3 Europe Eszopiclone Drug Price by Application (2021-2032)
- 9.3 Europe Eszopiclone Drug Market Size by Country
- 9.3.1 Europe Eszopiclone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Eszopiclone Drug Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Eszopiclone Drug Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Eszopiclone Drug Market Size by Type
- 10.1.1 China Eszopiclone Drug Revenue by Type (2021-2032)
- 10.1.2 China Eszopiclone Drug Sales by Type (2021-2032)
- 10.1.3 China Eszopiclone Drug Price by Type (2021-2032)
- 10.2 China Eszopiclone Drug Market Size by Application
- 10.2.1 China Eszopiclone Drug Revenue by Application (2021-2032)
- 10.2.2 China Eszopiclone Drug Sales by Application (2021-2032)
- 10.2.3 China Eszopiclone Drug Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Eszopiclone Drug Market Size by Type
- 11.1.1 Asia Eszopiclone Drug Revenue by Type (2021-2032)
- 11.1.2 Asia Eszopiclone Drug Sales by Type (2021-2032)
- 11.1.3 Asia Eszopiclone Drug Price by Type (2021-2032)
- 11.2 Asia Eszopiclone Drug Market Size by Application
- 11.2.1 Asia Eszopiclone Drug Revenue by Application (2021-2032)
- 11.2.2 Asia Eszopiclone Drug Sales by Application (2021-2032)
- 11.2.3 Asia Eszopiclone Drug Price by Application (2021-2032)
- 11.3 Asia Eszopiclone Drug Market Size by Country
- 11.3.1 Asia Eszopiclone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Eszopiclone Drug Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Eszopiclone Drug Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Eszopiclone Drug Market Size by Type
- 12.1.1 SAMEA Eszopiclone Drug Revenue by Type (2021-2032)
- 12.1.2 SAMEA Eszopiclone Drug Sales by Type (2021-2032)
- 12.1.3 SAMEA Eszopiclone Drug Price by Type (2021-2032)
- 12.2 SAMEA Eszopiclone Drug Market Size by Application
- 12.2.1 SAMEA Eszopiclone Drug Revenue by Application (2021-2032)
- 12.2.2 SAMEA Eszopiclone Drug Sales by Application (2021-2032)
- 12.2.3 SAMEA Eszopiclone Drug Price by Application (2021-2032)
- 12.3 SAMEA Eszopiclone Drug Market Size by Country
- 12.3.1 SAMEA Eszopiclone Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Eszopiclone Drug Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Eszopiclone Drug Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Eszopiclone Drug Value Chain Analysis
- 13.1.1 Eszopiclone Drug Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Eszopiclone Drug Production Mode & Process
- 13.2 Eszopiclone Drug Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Eszopiclone Drug Distributors
- 13.2.3 Eszopiclone Drug Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst